Samuel P. Sutherland, BS

Articles by Samuel P. Sutherland, BS

Resource Use Among Nonvalvular Atrial Fibrillation Patients

ByMatthew Sussman, MA,Sameer Ghate, PhD,Samuel P. Sutherland, BS,Cheng Wang, MD, PhD,Stephen Sander, PharmD,Robert I. Griffiths, ScD

October 19th 2016

This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.

Latest Updated Articles

Resource Use Among Nonvalvular Atrial Fibrillation Patients
Published: October 19th 2016 | Updated:

Samuel P. Sutherland, BS

Articles by Samuel P. Sutherland, BS

Resource Use Among Nonvalvular Atrial Fibrillation Patients

Latest Updated Articles

Trending on Pharmacy Times

Combination of Olezarsen and Fibrates Yields Enhanced Triglyceride Reduction

Influenza Hospitalizations in Children Reveal Significant Non-respiratory Complications

FDA Approves Aflibercept Injection to Treat Patients With Macular Edema Following RVO